Nuclear Localization of Cancer Stem Cell Marker CD133 in Triple-Negative Breast Cancer: A Case Report

Epigenetic Regulation of Cancer Stem Cell Genes in Triple-Negative Breast Cancer

(2012) Naofumi Kagara et al.   AMERICAN JOURNAL OF PATHOLOGY

Overexpression of Cell Cycle Progression Inhibitor Geminin is Associated with Tumor Stem-Like Phenotype of Triple-Negative Breast Cancer

(2012) Maurizio Di Bonito et al.   Journal of Breast Cancer

Aberrant Expression of Cancer Stem Cells Marker Prominin-1 in Low-Grade Tubulobular Breast Carcinoma: A Correlative Study between qRT-PCR, Flow-Cytometric and Immunohistochemistry Analysis

(2012) Maurizio Di Bonito et al.   Journal of Breast Cancer

Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers

(2012) Marina De Brot et al.   PATHOLOGY

Nuclear functions and subcellular trafficking mechanisms of the epidermal growth factor receptor family

(2012) Ying-Nai Wang et al.   Cell and Bioscience

Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma

(2011) Po Zhao et al.   CANCER SCIENCE

CD44+/CD24−/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome

(2011) Michael O. Idowu et al.   HUMAN PATHOLOGY

Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer

(2010) Anna L. Stratford et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Transportin Regulates Nuclear Import of CD44

(2010) Michalina Janiszewska et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The CD44+/CD24− phenotype relates to ‘triple-negative’ state and unfavorable prognosis in breast cancer patients

(2010) Alexandra Giatromanolaki et al.   MEDICAL ONCOLOGY

Acetylation and activation of STAT3 mediated by nuclear translocation of CD44

(2009) Jia-Lin Lee et al.   JOURNAL OF CELL BIOLOGY

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

(2009) C. J. Creighton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers

(2008) L M Smith et al.   BRITISH JOURNAL OF CANCER

The Stem Cell-Associated Antigen CD133 (Prominin-1) Is a Molecular Therapeutic Target for Metastatic Melanoma

(2008) Germana Rappa et al.   STEM CELLS